MEIP
MEI Pharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website meipharma.com
- Employees(FY) 46
- ISIN US55279B3015
Performance
+2.61%
1W
-1.56%
1M
-28.25%
3M
-48.7%
6M
-45.69%
YTD
-46.67%
1Y
Profile
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor for the treatment of patients with relapsed/refractory follicular lymphoma; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase I clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex which has completed Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer. MEI Pharma, Inc. has a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Technical Analysis of MEIP 2024-05-10
Overview:
In analyzing the technical indicators for MEIP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-09 10:57
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024(Investorplace)
- 2024-05-09 04:02
- 2024-04-10 20:02
- 2024-04-10 20:00
- 2024-04-09 20:00
- 2024-03-25 20:00
- 2024-03-09 00:09
- 2024-02-13 05:15
- 2024-02-13 04:05
- 2024-02-07 17:48
Is MEI Pharma (MEIP) Attractively Priced?(Insidermonkey)
- 2024-01-16 04:00
- 2023-12-10 23:00
- 2023-11-26 21:33
11 Cheapest Stocks With Biggest Upside(Yahoo Finance)
- 2023-11-09 03:05
- 2023-11-07 19:00
- 2023-11-06 03:57
- 2023-11-01 23:23
Corcept (CORT) Beats on Q3 Earnings, Raises '23 Sales View(Yahoo Finance)
- 2023-11-01 21:00
- 2023-11-01 00:03
Amarin (AMRN) Q3 Earnings and Revenues Surpass Estimates(Yahoo Finance)
- 2023-10-31 21:00
- 2023-10-19 23:43
BEAM to Reprioritize Portfolio, Slash Jobs, Shares Tank(Yahoo Finance)
- 2023-10-17 23:13
- 2023-10-17 05:33
MEI Pharma Recommends Stockholders Not to Consent(Businesswire)
- 2023-10-16 23:47
- 2023-10-16 23:30
- 2023-10-16 00:53
- 2023-10-09 22:54
Anson and Cable Car Send Letter to MEI Pharma Stockholders(Globenewswire)
- 2023-10-01 18:00
- 2023-09-29 00:00
- 2023-09-28 05:00
Page 1 of 4
previousnext